Bioadaptives, Inc. (BDPT): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$534.0K

Year ended 2025-12-31

-$436.4K

Trailing 12 months to 2026-06-30

2014-12-31 Free Cash Flow (USD) 2025-12-31

Period ended	Free Cash Flow	Change YoY	Source filing
2025-12-31	-$534.0K	n/m	2026-04-14, From 2025-01-01
2024-12-31	-$249.5K	n/a	2026-04-14, From 2024-01-01
No annual figure between 2014-12-31 and 2024-12-31.
2014-12-31	-$57.0K	n/a	2016-04-14, From 2014-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Free Cash Flow	Change YoY
Bioadaptives, Inc. (BDPT)	2025-12-31	-$534.0K	n/m
PRF Technologies Ltd. (PRFX)	2025-12-31	-$3.96M	n/m
Skinvisible, Inc. (SKVI)	2025-12-31	-$42.5K	n/m
Talphera, Inc. (TLPH)	2024-12-31	-$12.68M	n/m
Lyell Immunopharma, Inc. (LYEL)	2025-12-31	-$150.80M	n/m
Neonc Technologies Holdings, Inc. (NTHI)	2025-12-31	-$20.86M	n/a
Altimmune, Inc. (ALT)	2025-12-31	-$67.55M	n/a
Genelux Corp (GNLX)	2025-12-31	-$26.37M	n/m
HCW Biologics Inc. (HCWB)	2025-12-31	-$13.39M	n/m

Compare BDPT, PRFX, SKVI, TLPH side by side · Screen every company in Pharmaceutical Preparations ↗